2-61017692-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The ENST00000444100.2(PEX13):​c.-68C>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)

Consequence

PEX13
ENST00000444100.2 5_prime_UTR_premature_start_codon_gain

Scores

2
Splicing: ADA: 0.00009112
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.467

Publications

0 publications found
Variant links:
Genes affected
PEX13 (HGNC:8855): (peroxisomal biogenesis factor 13) This gene encodes a peroxisomal membrane protein that binds the type 1 peroxisomal targeting signal receptor via a SH3 domain located in the cytoplasm. Mutations and deficiencies in peroxisomal protein importing and peroxisome assembly lead to peroxisomal biogenesis disorders, an example of which is Zellweger syndrome. [provided by RefSeq, Oct 2008]
PUS10 (HGNC:26505): (pseudouridine synthase 10) Pseudouridination, the isomerization of uridine to pseudouridine, is the most common posttranscriptional nucleotide modification found in RNA and is essential for biologic functions such as spliceosome biogenesis. Pseudouridylate synthases, such as PUS10, catalyze pseudouridination of structural RNAs, including transfer, ribosomal, and splicing RNAs. These enzymes also act as RNA chaperones, facilitating the correct folding and assembly of tRNAs (McCleverty et al., 2007 [PubMed 17900615]).[supplied by OMIM, May 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000444100.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PUS10
NM_144709.4
MANE Select
c.-16+316G>C
intron
N/ANP_653310.2Q3MIT2
PUS10
NM_001322127.1
c.-623+316G>C
intron
N/ANP_001309056.1
PEX13
NM_002618.4
MANE Select
c.-68C>G
upstream_gene
N/ANP_002609.1Q92968

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PEX13
ENST00000444100.2
TSL:1
c.-68C>G
5_prime_UTR_premature_start_codon_gain
Exon 1 of 2ENSP00000405184.2D3YTD3
PEX13
ENST00000444100.2
TSL:1
c.-68C>G
5_prime_UTR
Exon 1 of 2ENSP00000405184.2D3YTD3
PUS10
ENST00000316752.11
TSL:1 MANE Select
c.-16+316G>C
intron
N/AENSP00000326003.6Q3MIT2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
15
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
9.2
DANN
Benign
0.44
PhyloP100
0.47
PromoterAI
0.021
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000091
dbscSNV1_RF
Benign
0.010
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs571713221; hg19: chr2-61244827; API